ArticleCrohn's & colitis 3602024
Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease.
Erratum issuedAbstract read
In one paragraph
Article in Crohn's & colitis 360, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Raising the Bar in Crohn's Disease: Is Transmural Healing Achievable?Diagnostics (Basel, Switzerland) · 2026Review
- Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry.United European gastroenterology journal · 2026Observational
- Upadacitinib as rescue therapy for acute severe ulcerative colitis and severe Crohn's disease - current knowledge and future directions.Pharmacological reports : PR · 2026Review
- A Real-World Study of Upadacitinib in Anti-TNF Refractory Crohn's Disease: Effectiveness, Persistence, and Safety.Journal of inflammation research · 2026Article
- Postoperative Recurrence in Crohn's Disease: Pathophysiology, Risk Stratification, and Management Strategies.Journal of clinical medicine · 2025Review
- Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn's Disease: A Prospective Study.Journal of clinical medicine · 2025Article
- Is Transmural Healing an Achievable Goal in Inflammatory Bowel Disease?Pharmaceuticals (Basel, Switzerland) · 2025Review
- Optimizing Biologic Therapy for the Prevention of Post-Operative Recurrence in Crohn's Disease: Current Evidence and Future Perspectives.Biomedicines · 2025Review
- Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study.Alimentary pharmacology & therapeutics · 2025Article
- Efficacy and Safety of Upadacitinib and Vedolizumab Combination for Refractory Orofacial Granulomatosis Associated with Panenteric Crohn's Disease: A Case Report.Reports (MDPI) · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
28 authors.
Cristina BezzioGastroenterology Department, IBD Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.ORCID https://orcid.org/0000-0003-0076-8549
Gianluca FranchellucciGastroenterology Department, IBD Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Edoardo V SavarinoDivision of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Mauro MastronardiDepartment of Gastroenterology, S. de Bellis National Institute of Gastroenterology, Castellana Grotte, Italy.
Flavio Andrea CaprioliGastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Giorgia BodiniDepartment of Internal Medicine, IRCCS Policlinico San Martino, Università di Genova, Genoa, Italy.
Angela VariolaIBD Unit, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar di Valpolicella, Italy.
Franco ScaldaferriIBD Unit, CEMAD, Digestive Diseases Center, Medicina Interna e Gastroenterologia. Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.
Federica FurfaroDepartment of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
Emma CalabreseDepartment of Systems Medicine, Gastroenterology Unit, University of Rome "Tor Vergata," Rome, Italy.ORCID https://orcid.org/0000-0002-2177-0421
Maria Beatrice PrincipiDepartment of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Gastroenterology Unit, University of Bari "Aldo Moro," Bari (BA), Italy.
Giuseppe BiscagliaDivision of Gastroenterology, Fondazione IRCCS "Casa Sollievo della Sofferenza," San Giovanni Rotondo, Italy.ORCID https://orcid.org/0000-0002-0019-7929
Manuela MarzoDivision of Gastroenterology, Veris-Delli Ponti Hospital, Scorrano, Italy.
Andrea MichielanAzienda Provinciale per i Servizi Sanitari (APSS), Gastroenterology and Digestive Endoscopy Unit, Santa Chiara Hospital, Trento, Italy.
Carolina CavalliGastroenterology Unit, Santa Maria Degli Angeli Hospital, Pordenone, Italy.
Annalisa AratariIBD Unit, S. Filippo Neri Hospital, Rome, Italy.
Michele CampigottoDepartment of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
Linda CeccarelliDepartment of Translational Sciences and New Technologies in Medicine and Surgery, Gastrointestinal Unit, University of Pisa, Pisa, Italy.
Maria CappelloProMISE Department, Gastroenterology and Hepatology Section, University of Palermo, Palermo, Italy.
Simone SaibeniGastroenterology Unit, Rho Hospital, ASST Rhodense, Rho, Italy.ORCID https://orcid.org/0000-0001-5677-2534
Paola BalestrieriUnit of Gastroenterology and Digestive Endoscopy, Campus Bio-Medico University, Rome, Italy.
Alessandra SorianoGastroenterology Division, Internal Medicine Department, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy.
Valentina CasiniUnit of Gastroenterology and Digestive Endoscopy, ASST Bergamo Est, Bolognini Hospital, Seriate (BG), Italy.
Lorenzo BertaniDepartment of General Surgery and Gastroenterology, Tuscany Northwest ASL-Pontedera Hospital, Pontedera, Italy.
Brigida BarberioDivision of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Francesco Simone ConfortiGastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Silvio DaneseDepartment of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
Alessandro ArmuzziGastroenterology Department, IBD Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.ORCID https://orcid.org/0000-0003-1572-0118
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Crohn’s diseasedifficult-to-treat IBDeffectivenessremissionresponseupadacitinib
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.